These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36877951)

  • 21. Combining paclitaxel and lapatinib as second-line treatment for patients with metastatic transitional cell carcinoma: a case series.
    Culine S; Sellam Z; Bouaita L; Assaf E; Delbaldo C; Verlinde-Carvalho M; Pouessel D
    Anticancer Res; 2012 Sep; 32(9):3949-52. PubMed ID: 22993342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enfortumab vedotin and pembrolizumab as new first-line standard for metastatic urothelial cancer.
    Zhu X; Koshkin VS
    Med; 2024 Feb; 5(2):106-108. PubMed ID: 38128535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combination chemotherapy with M-VAC protocol in metastatic urothelial cancer].
    Sella A; Flex D; Gafni D; Rabinovitz O; Sulkes A; Baniel J
    Harefuah; 1999 Feb; 136(4):268-71, 340, 339. PubMed ID: 10914214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new era in the treatment of urothelial carcinoma.
    Faltas B
    Urol Oncol; 2023 Oct; 41(10):395-397. PubMed ID: 37833099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The future of drug development in urothelial cancer.
    Dreicer R
    J Clin Oncol; 2012 Feb; 30(5):473-5. PubMed ID: 22184400
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemotherapy of metastatic bladder cancer.
    Yagoda A
    Cancer; 1980 Apr; 45(7 Suppl):1879-88. PubMed ID: 7189443
    [No Abstract]   [Full Text] [Related]  

  • 27. Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trial.
    Nishiyama H; Yamamoto Y; Sassa N; Nishimura K; Fujimoto K; Fukasawa S; Yokoyama M; Enokida H; Takahashi K; Tanaka Y; Imai K; Shimamoto T; Perini R; Frenkl T; Bajorin D; Bellmunt J
    Int J Clin Oncol; 2020 Jan; 25(1):165-174. PubMed ID: 31729625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is HER2 the New NECTIN4 in Advanced Urothelial Cancer?
    Nally E; Young M; Wells C; Fairhead R; Baines K; Cheney-Lowe H; Jackson-Spence F; Powles T
    Eur Urol Focus; 2024 Mar; 10(2):219-221. PubMed ID: 38825408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug approval: Enfortumab vedotin-advanced urothelial carcinoma (which have previously received platinum-containing chemotherapy and immunotherapy)].
    Matte P; Campedel L
    Bull Cancer; 2022; 109(7-8):738-740. PubMed ID: 35606195
    [No Abstract]   [Full Text] [Related]  

  • 30. Highlights from the 2024 ASCO Genitourinary Symposium: focus on urothelial and prostate cancer.
    Strusi A; Pinterpe G; Ciccarese C; Pedone RR; Sarcina M; Sardaro V; Belletto R; Totaro A; Racioppi M; Berardi R; Tortora G; Iacovelli R
    Expert Rev Anticancer Ther; 2024 Aug; 24(8):661-664. PubMed ID: 38932631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second-line treatment of advanced transitional cell carcinoma of the urothelial tract.
    Sternberg CN
    Curr Opin Urol; 2001 Sep; 11(5):523-9. PubMed ID: 11493775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The first Slovak experience with second-line vinflunine in advanced urothelial carcinomas.
    Palacka P; Mego M; Obertova J; Chovanec M; Sycova-Mila Z; Mardiak J
    Klin Onkol; 2014; 27(6):429-33. PubMed ID: 25493582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of adjuvant gemcitabine-cisplatin chemotherapy: a comparative study between locally advanced transitional cell carcinoma of the bladder and upper urinary tract.
    Song YS; Cho JS; Cho KS; Doo SH; Chung BH; Kim SJ; Yang WJ; Song KH; Kim CI; Hong SJ
    Urol Int; 2010; 85(1):47-51. PubMed ID: 20234122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weekly regimen of epirubicin and paclitaxel as second-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study.
    Rozzi A; Salerno M; Bordin F; De Marco F; Di Nicola S; Lanzetta G
    Med Oncol; 2011 Dec; 28 Suppl 1():S426-32. PubMed ID: 21116878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents.
    Tully CM; Apolo AB; Zabor EC; Regazzi AM; Ostrovnaya I; Furberg HF; Rosenberg JE; Bajorin DF
    Cancer; 2016 Mar; 122(5):712-21. PubMed ID: 26618338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second Line Chemotherapy for Advanced and Metastatic Urothelial Carcinoma: Vinflunine and Beyond-A Comprehensive Review of the Current Literature.
    Oing C; Rink M; Oechsle K; Seidel C; von Amsberg G; Bokemeyer C
    J Urol; 2016 Feb; 195(2):254-63. PubMed ID: 26410730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pembrolizumab plus enfortumab vedotin in urothelial cancer.
    Santoni M; Takeshita H; Massari F; Bamias A; Cerbone L; Fiala O; Mollica V; Buti S; Santoni A; Bellmunt J
    Nat Rev Urol; 2024 Jul; 21(7):387-388. PubMed ID: 38267716
    [No Abstract]   [Full Text] [Related]  

  • 38. Systemic chemotherapy of transitional cell carcinoma of the urothelium.
    Chun HG; Dorr FA
    Cancer Treat Res; 1989; 42():151-74. PubMed ID: 2577102
    [No Abstract]   [Full Text] [Related]  

  • 39. [PPA (cis-platinum), peplomycin and adriamycin) combination chemotherapy in transitional cell carcinoma of the urothelial tract--pilot study].
    Ono Y; Ohshima S; Fujita T; Naide Y; Suzuki K; Asoh Y; Fukushima M; Ohta K
    Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):28-33. PubMed ID: 2422307
    [No Abstract]   [Full Text] [Related]  

  • 40. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.
    Sternberg CN; Yagoda A; Scher HI; Watson RC; Geller N; Herr HW; Morse MJ; Sogani PC; Vaughan ED; Bander N
    Cancer; 1989 Dec; 64(12):2448-58. PubMed ID: 2819654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.